Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $467.70. The company's market cap stands at 253.28B, with a P/E ratio of 26.98 and a dividend yield of 2.14%.
On 2026-11-11, Amgen(AMGN) stock moved within a range of $459.02 to $468.46. With shares now at $467.70, the stock is trading +1.9% above its intraday low and -0.2% below the session's peak.
Trading activity shows a volume of 1.88M, compared to an average daily volume of 2.95M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $483.99 and a low of $312.39.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $483.99 and a low of $312.39.
AMGN News
...
Amgen (NasdaqGS:AMGN) received an FDA warning letter regarding a Vectibix promotional video that omitted key risk and indication details. The FDA letter cites...
Amgen Inc. (NASDAQ:AMGN) announced positive Phase 3 results showing dazodalibep significantly reduced systemic disease activity and key symptoms in patients wit...
Analyst ratings
54%
of 37 ratingsMore AMGN News
Amgen (AMGN) shares fell in premarket trading on Wednesday after the California-based pharma giant announced detailed results from a late-stage trial for dazoda...
Technology Amgen, In A Buy Zone, Unveils Highly Anticipated Novartis-Rivaling Sjogren's Data Licensing After several high-profile setbacks among its competitors...
It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...
Amgen (AMGN) has been in focus after a packed early November. Fresh third quarter figures, new real world Repatha data and progress in obesity and autoimmune pr...
Biotech stocks have performed well in 2026, but things could change fairly rapidly. The industry is notoriously volatile, after all, and there are significant r...
Amgen reported third quarter 2026 revenue of US$10.365b and net income of US$3.864b, alongside fresh real world data showing Repatha cut heart attack risk by 20...
has been a strong performer in large-cap biotech, and with the stock recently around US$460 per share the key question for you is how well that price lines up w...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.